Swiss National Bank cut its stake in LHC Group, Inc. (NASDAQ:LHCG) by 0.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 67,866 shares of the health services provider’s stock after selling 100 shares during the period. Swiss National Bank owned 0.21% of LHC Group worth $14,477,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Point72 Hong Kong Ltd acquired a new stake in LHC Group in the third quarter worth $25,000. Parallel Advisors LLC increased its position in LHC Group by 100.0% in the fourth quarter. Parallel Advisors LLC now owns 124 shares of the health services provider’s stock worth $26,000 after buying an additional 62 shares during the period. Altshuler Shaham Ltd acquired a new stake in LHC Group in the third quarter worth $27,000. Fieldpoint Private Securities LLC acquired a new stake in LHC Group in the fourth quarter worth $27,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in LHC Group in the third quarter worth $30,000. 91.82% of the stock is currently owned by hedge funds and other institutional investors.
Several research firms have recently issued reports on LHCG. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating and set a $228.00 price target for the company. in a research note on Tuesday, November 3rd. Deutsche Bank Aktiengesellschaft increased their price target on LHC Group from $240.00 to $260.00 and gave the stock a “buy” rating in a research note on Monday, February 8th. They noted that the move was a valuation call. Oppenheimer reissued a “buy” rating on shares of LHC Group in a research note on Tuesday, November 17th. Credit Suisse Group assumed coverage on LHC Group in a research note on Monday, January 25th. They issued an “outperform” rating and a $255.00 price target for the company. Finally, Truist raised their target price on LHC Group from $245.00 to $260.00 in a research note on Tuesday, January 5th. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $220.73.
LHC Group Company Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Featured Article: What moving averages are used to define a golden cross?
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.